Latvia - Diabetes Medicine Use
Since 2014, Latvia Diabetes Medicine Use jumped by 2.7% year on year. At 48.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was number 26 among other countries in Diabetes Medicine Use. Latvia is overtaken by Iceland, which was ranked number 25 with 48.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Chile with 48 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Finland lead the ranking with 97.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, +1.6% compared to 2018. Czech Republic, Canada and United Kingdom respectively ranked number 2, 3 and 4 in this ranking. Canada witnessed the best average annual growth at +9.6% per year, while Chile recorded the worst performance at -1.6% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 48.50 |
| 2018 | 46.70 |
| 2017 | 45.50 |
| 2016 | 43.60 |
| 2015 | 43.80 |
How does Latvia rank in Diabetes Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Finland
|
97 | 2019 | +1.6 % | +2.0 % | View data | |
| 2 |
#2
Czech Republic
|
93 | 2019 | +2.8 % | +1.9 % | View data | |
| 25 |
#25
Iceland
|
49 | 2019 | +0.4 % | +2.8 % | View data | |
| 26 |
#26
Latvia
|
49 | 2019 | +3.9 % | +2.7 % | View data | |
| 27 |
#27
Chile
|
48 | 2019 | +0.2 % | -1.6 % | View data | |